돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 221368생성일: 2026년 10월 26일

3-Chloropyridine → 4-(3-Pyridin-4-yl-[1,2,4]oxadiazol-5-ylmethoxy)-3,4,5,6-tetrahydro-2H-[1,3']bipyridinyl

https://huagongshe.com/reaction/221368

반응식

참여 물질

역할이름HCID투입량
반응물3-ChloropyridineHCID 12287—
반응물Sodium t-butoxideHCID 23676156—
반응물4-[5-(Piperidin-4-yloxymethyl)-[1,2,4]oxadiazol-3-yl]-pyridineHCID 57954397—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매TolueneHCID 1140—
생성물4-(3-Pyridin-4-yl-[1,2,4]oxadiazol-5-ylmethoxy)-3,4,5,6-tetrahydro-2H-[1,3']bipyridinylHCID 57954375—

반응 조건

온도80 °C

반응 단계

Sodium tert-butoxide (86 mg, 900 μmol) was added to a solution of 3-chloropyridine (23 mg, 200 μmol), 4-[5-(piperidin-4-yloxymethyl)[1,2,4]oxadiazol-3-yl]pyridine (Preparation 17, 65 mg, 250 μmol), Pd2 dba3 (4 mg, 4 μmol) and 2,8,9-trisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane (6 mg, 16 μmol) in toluene (3 ml) and the resulting mixture heated at 80° C. for 48 h. After cooling and filtering through celite, the solvent was removed and the residue purified by HPLC to afford the title compound: RT=2.64 min; m/z (ES+)=338.0 [M+H]+.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08207147B2
출처 데이터셋uspto-grants-2012_06
ORD IDord-9087b8d7f6164ccfa1636c0331c8aa98
출처 메모uspto-grants-2012_06